Found 96 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160718
(CHEMBL3786344)Show SMILES CCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C30H42Cl2N8O2/c1-38-26(17-25(37-38)22-7-4-8-23(31)27(22)32)20-11-14-39(15-12-20)30(42)35-13-9-24(36-29(33)34)28(41)40-16-10-19-5-2-3-6-21(19)18-40/h4,7-8,17,19-21,24H,2-3,5-6,9-16,18H2,1H3,(H,35,42)(H4,33,34,36)/t19?,21?,24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160718
(CHEMBL3786344)Show SMILES CCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C30H42Cl2N8O2/c1-38-26(17-25(37-38)22-7-4-8-23(31)27(22)32)20-11-14-39(15-12-20)30(42)35-13-9-24(36-29(33)34)28(41)40-16-10-19-5-2-3-6-21(19)18-40/h4,7-8,17,19-21,24H,2-3,5-6,9-16,18H2,1H3,(H,35,42)(H4,33,34,36)/t19?,21?,24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160716
(CHEMBL3785198)Show SMILES CC(C)(CN1C(C(=O)NCCCC(F)F)c2ccccc2C1=O)c1ccc(F)cc1 Show InChI InChI=1S/C25H36Cl2N8O2/c1-4-34(5-2)23(36)19(31-24(28)29)9-12-30-25(37)35-13-10-16(11-14-35)21-15-20(32-33(21)3)17-7-6-8-18(26)22(17)27/h6-8,15-16,19H,4-5,9-14H2,1-3H3,(H,30,37)(H4,28,29,31)/t19-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160712
(CHEMBL3785768)Show SMILES CC(C)(CN1C(C(=O)NCCCF)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-13(26-20(23)24)6-9-25-32(30,31)29-10-7-14(8-11-29)18-12-17(27-28(18)2)15-4-3-5-16(21)19(15)22/h3-5,12-14,25H,6-11H2,1-2H3,(H4,23,24,26)/t13-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160704
(CHEMBL3785486)Show SMILES CCCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H27Cl2N7O3/c1-29-17(11-16(28-29)13-3-2-4-14(22)18(13)23)12-6-9-30(10-7-12)21(33)26-8-5-15(19(31)32)27-20(24)25/h2-4,11-12,15H,5-10H2,1H3,(H,26,33)(H,31,32)(H4,24,25,27)/t15-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160712
(CHEMBL3785768)Show SMILES CC(C)(CN1C(C(=O)NCCCF)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-13(26-20(23)24)6-9-25-32(30,31)29-10-7-14(8-11-29)18-12-17(27-28(18)2)15-4-3-5-16(21)19(15)22/h3-5,12-14,25H,6-11H2,1-2H3,(H4,23,24,26)/t13-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160743
(CHEMBL3785621)Show SMILES COc1ccc2C(N(Cc3ccccc3-c3ccccc3)C(=O)c2c1C)C(=O)NC(C)(C)C Show InChI InChI=1S/C28H30N2O3/c1-18-23(33-5)16-15-22-24(18)27(32)30(25(22)26(31)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25H,17H2,1-5H3,(H,29,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160697
(CHEMBL3785335)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-13(27-20(24)25)6-9-26-21(31)30-10-7-14(8-11-30)18-12-17(28-29(18)2)15-4-3-5-16(22)19(15)23/h3-5,12-14H,6-11H2,1-2H3,(H,26,31)(H4,24,25,27)/t13-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160697
(CHEMBL3785335)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-13(27-20(24)25)6-9-26-21(31)30-10-7-14(8-11-30)18-12-17(28-29(18)2)15-4-3-5-16(22)19(15)23/h3-5,12-14H,6-11H2,1-2H3,(H,26,31)(H4,24,25,27)/t13-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 800 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160747
(CHEMBL3785933)Show SMILES CCCCNC(=O)C1N(CC(C)c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H25FN2O2/c1-3-4-13-24-21(26)20-18-7-5-6-8-19(18)22(27)25(20)14-15(2)16-9-11-17(23)12-10-16/h5-12,15,20H,3-4,13-14H2,1-2H3,(H,24,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160712
(CHEMBL3785768)Show SMILES CC(C)(CN1C(C(=O)NCCCF)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-13(26-20(23)24)6-9-25-32(30,31)29-10-7-14(8-11-29)18-12-17(27-28(18)2)15-4-3-5-16(21)19(15)22/h3-5,12-14,25H,6-11H2,1-2H3,(H4,23,24,26)/t13-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160704
(CHEMBL3785486)Show SMILES CCCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H27Cl2N7O3/c1-29-17(11-16(28-29)13-3-2-4-14(22)18(13)23)12-6-9-30(10-7-12)21(33)26-8-5-15(19(31)32)27-20(24)25/h2-4,11-12,15H,5-10H2,1H3,(H,26,33)(H,31,32)(H4,24,25,27)/t15-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160733
(CHEMBL3787444)Show SMILES CC(CN1C(C(=O)NCC(F)F)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H19ClF2N2O2/c1-12(13-6-8-14(21)9-7-13)11-25-18(19(26)24-10-17(22)23)15-4-2-3-5-16(15)20(25)27/h2-9,12,17-18H,10-11H2,1H3,(H,24,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160692
(CHEMBL3785810)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OC(F)F Show InChI InChI=1S/C23H33Cl2N7O/c1-14(2)18(29-22(26)27)7-10-28-23(33)32-11-8-15(9-12-32)20-13-19(30-31(20)3)16-5-4-6-17(24)21(16)25/h4-6,13-15,18H,7-12H2,1-3H3,(H,28,33)(H4,26,27,29)/t18-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160710
(CHEMBL3785427)Show SMILES CC(C)(CN1C(C(=O)NCC(F)F)c2ccccc2C1=O)c1ccc(F)cc1 Show InChI InChI=1S/C26H33Cl2N7O6S/c1-33(26(29)30)11-3-10-31-42(38,39)35-12-8-16(9-13-35)20-14-19(32-34(20)2)18-5-7-21(24(28)23(18)27)40-15-17-4-6-22(41-17)25(36)37/h4-7,14,16,31H,3,8-13,15H2,1-2H3,(H3,29,30)(H,36,37) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160714
(CHEMBL3785721)Show SMILES CCCCNC(=O)C1N(CC(C)(O)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H29Cl2N7O3/c1-30-18(12-17(29-30)14-4-3-5-15(23)19(14)24)13-7-10-31(11-8-13)22(33)27-9-6-16(20(32)34-2)28-21(25)26/h3-5,12-13,16H,6-11H2,1-2H3,(H,27,33)(H4,25,26,28)/t16-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160694
(CHEMBL3786683)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OCF Show InChI InChI=1S/C19H27Cl2N7O2S/c1-27-17(12-16(26-27)14-4-2-5-15(20)18(14)21)13-6-10-28(11-7-13)31(29,30)25-9-3-8-24-19(22)23/h2,4-5,12-13,25H,3,6-11H2,1H3,(H4,22,23,24) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160701
(CHEMBL3786519)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-3-11-30(22(25)26)12-5-10-27-34(32,33)31-13-8-16(9-14-31)20-15-19(28-29(20)2)17-6-4-7-18(23)21(17)24/h4,6-7,15-16,27H,3,5,8-14H2,1-2H3,(H3,25,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160702
(CHEMBL3787088)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C18H25Cl2N7O2S/c1-26-16(11-15(25-26)13-3-2-4-14(19)17(13)20)12-5-9-27(10-6-12)30(28,29)24-8-7-23-18(21)22/h2-4,11-12,24H,5-10H2,1H3,(H4,21,22,23) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160702
(CHEMBL3787088)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C18H25Cl2N7O2S/c1-26-16(11-15(25-26)13-3-2-4-14(19)17(13)20)12-5-9-27(10-6-12)30(28,29)24-8-7-23-18(21)22/h2-4,11-12,24H,5-10H2,1H3,(H4,21,22,23) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160699
(CHEMBL3786460)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)c(F)c2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160699
(CHEMBL3786460)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)c(F)c2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160566
(CHEMBL3786255)Show SMILES CC(N1C(C(=O)NCc2ccccc2)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C24H22N2O2/c1-17(19-12-6-3-7-13-19)26-22(20-14-8-9-15-21(20)24(26)28)23(27)25-16-18-10-4-2-5-11-18/h2-15,17,22H,16H2,1H3,(H,25,27) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160694
(CHEMBL3786683)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OCF Show InChI InChI=1S/C19H27Cl2N7O2S/c1-27-17(12-16(26-27)14-4-2-5-15(20)18(14)21)13-6-10-28(11-7-13)31(29,30)25-9-3-8-24-19(22)23/h2,4-5,12-13,25H,3,6-11H2,1H3,(H4,22,23,24) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160700
(CHEMBL3785765)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C23H33Cl2N7O/c1-14(2)18(29-22(26)27)7-10-28-23(33)32-11-8-15(9-12-32)20-13-19(30-31(20)3)16-5-4-6-17(24)21(16)25/h4-6,13-15,18H,7-12H2,1-3H3,(H,28,33)(H4,26,27,29)/t18-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160700
(CHEMBL3785765)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C23H33Cl2N7O/c1-14(2)18(29-22(26)27)7-10-28-23(33)32-11-8-15(9-12-32)20-13-19(30-31(20)3)16-5-4-6-17(24)21(16)25/h4-6,13-15,18H,7-12H2,1-3H3,(H,28,33)(H4,26,27,29)/t18-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160744
(CHEMBL3787356)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cccc(O)c12 Show InChI InChI=1S/C26H26N2O3/c1-26(2,3)27-24(30)23-22-20(14-9-15-21(22)29)25(31)28(23)16-18-12-7-8-13-19(18)17-10-5-4-6-11-17/h4-15,23,29H,16H2,1-3H3,(H,27,30) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160743
(CHEMBL3785621)Show SMILES COc1ccc2C(N(Cc3ccccc3-c3ccccc3)C(=O)c2c1C)C(=O)NC(C)(C)C Show InChI InChI=1S/C28H30N2O3/c1-18-23(33-5)16-15-22-24(18)27(32)30(25(22)26(31)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25H,17H2,1-5H3,(H,29,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160695
(CHEMBL3786868)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccc(cc12)C#N Show InChI InChI=1S/C23H33Cl2N7O/c1-3-11-31(22(26)27)12-5-10-28-23(33)32-13-8-16(9-14-32)20-15-19(29-30(20)2)17-6-4-7-18(24)21(17)25/h4,6-7,15-16H,3,5,8-14H2,1-2H3,(H3,26,27)(H,28,33) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160708
(CHEMBL3786775)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccc(F)cc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C20H29Cl2N7O2S/c1-28-18(13-17(27-28)15-5-4-6-16(21)19(15)22)14-7-11-29(12-8-14)32(30,31)26-10-3-2-9-25-20(23)24/h4-6,13-14,26H,2-3,7-12H2,1H3,(H4,23,24,25) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160744
(CHEMBL3787356)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cccc(O)c12 Show InChI InChI=1S/C26H26N2O3/c1-26(2,3)27-24(30)23-22-20(14-9-15-21(22)29)25(31)28(23)16-18-12-7-8-13-19(18)17-10-5-4-6-11-17/h4-15,23,29H,16H2,1-3H3,(H,27,30) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160695
(CHEMBL3786868)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccc(cc12)C#N Show InChI InChI=1S/C23H33Cl2N7O/c1-3-11-31(22(26)27)12-5-10-28-23(33)32-13-8-16(9-14-32)20-15-19(29-30(20)2)17-6-4-7-18(24)21(17)25/h4,6-7,15-16H,3,5,8-14H2,1-2H3,(H3,26,27)(H,28,33) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160707
(CHEMBL3785370)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccc(F)c(F)c3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C23H32Cl2N8O2/c1-31(2)21(34)17(29-22(26)27)7-10-28-23(35)33-11-8-14(9-12-33)19-13-18(30-32(19)3)15-5-4-6-16(24)20(15)25/h4-6,13-14,17H,7-12H2,1-3H3,(H,28,35)(H4,26,27,29)/t17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160719
(CHEMBL3787412)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1NS(C)(=O)=O Show InChI InChI=1S/C28H31N3O4S/c1-18-23(30-36(5,34)35)16-15-22-24(18)27(33)31(25(22)26(32)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25,30H,17H2,1-5H3,(H,29,32) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160566
(CHEMBL3786255)Show SMILES CC(N1C(C(=O)NCc2ccccc2)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C24H22N2O2/c1-17(19-12-6-3-7-13-19)26-22(20-14-8-9-15-21(20)24(26)28)23(27)25-16-18-10-4-2-5-11-18/h2-15,17,22H,16H2,1H3,(H,25,27) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160705
(CHEMBL3786303)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C23H33Cl2N7O/c1-15(2)32(22(26)27)11-5-10-28-23(33)31-12-8-16(9-13-31)20-14-19(29-30(20)3)17-6-4-7-18(24)21(17)25/h4,6-7,14-16H,5,8-13H2,1-3H3,(H3,26,27)(H,28,33) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160713
(CHEMBL3787069)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(O)ccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-29-18(13-17(28-29)15-5-4-6-16(22)19(15)23)14-7-11-30(12-8-14)21(31)27-10-3-2-9-26-20(24)25/h4-6,13-14H,2-3,7-12H2,1H3,(H,27,31)(H4,24,25,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 6.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160717
(CHEMBL3787036)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(NS(C)(=O)=O)ccc12 Show InChI InChI=1S/C24H35Cl2N7O/c1-15(2)13-17(30-23(27)28)7-10-29-24(34)33-11-8-16(9-12-33)21-14-20(31-32(21)3)18-5-4-6-19(25)22(18)26/h4-6,14-17H,7-13H2,1-3H3,(H,29,34)(H4,27,28,30)/t17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 7.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160713
(CHEMBL3787069)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(O)ccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-29-18(13-17(28-29)15-5-4-6-16(22)19(15)23)14-7-11-30(12-8-14)21(31)27-10-3-2-9-26-20(24)25/h4-6,13-14H,2-3,7-12H2,1H3,(H,27,31)(H4,24,25,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 8.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160706
(CHEMBL3786473)Show SMILES CC(N1C(C(=O)NC(C)(C)CO)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C27H37Cl2N9O3/c1-17(39)36-12-14-37(15-13-36)25(40)21(33-26(30)31)6-9-32-27(41)38-10-7-18(8-11-38)23-16-22(34-35(23)2)19-4-3-5-20(28)24(19)29/h3-5,16,18,21H,6-15H2,1-2H3,(H,32,41)(H4,30,31,33)/t21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by QPatch-clamp method |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.04E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160693
(CHEMBL3786256)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OS(C)(=O)=O Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160696
(CHEMBL3785555)Show SMILES COc1ccc2C(N(Cc3ccccc3-c3ccccc3)C(=O)c2c1)C(=O)NC(C)(C)C Show InChI InChI=1S/C27H38Cl2N8O2/c1-3-36(16-17-7-8-17)25(38)21(33-26(30)31)9-12-32-27(39)37-13-10-18(11-14-37)23-15-22(34-35(23)2)19-5-4-6-20(28)24(19)29/h4-6,15,17-18,21H,3,7-14,16H2,1-2H3,(H,32,39)(H4,30,31,33)/t21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.13E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160703
(CHEMBL3786013)Show SMILES O=C(NCc1ccncc1)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C20H27Cl2N7O/c1-28-17(12-16(27-28)14-4-2-5-15(21)18(14)22)13-6-10-29(11-7-13)20(30)26-9-3-8-25-19(23)24/h2,4-5,12-13H,3,6-11H2,1H3,(H,26,30)(H4,23,24,25) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160717
(CHEMBL3787036)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(NS(C)(=O)=O)ccc12 Show InChI InChI=1S/C24H35Cl2N7O/c1-15(2)13-17(30-23(27)28)7-10-29-24(34)33-11-8-16(9-12-33)21-14-20(31-32(21)3)18-5-4-6-19(25)22(18)26/h4-6,14-17H,7-13H2,1-3H3,(H,29,34)(H4,27,28,30)/t17-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160717
(CHEMBL3787036)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(NS(C)(=O)=O)ccc12 Show InChI InChI=1S/C24H35Cl2N7O/c1-15(2)13-17(30-23(27)28)7-10-29-24(34)33-11-8-16(9-12-33)21-14-20(31-32(21)3)18-5-4-6-19(25)22(18)26/h4-6,14-17H,7-13H2,1-3H3,(H,29,34)(H4,27,28,30)/t17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160692
(CHEMBL3785810)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OC(F)F Show InChI InChI=1S/C23H33Cl2N7O/c1-14(2)18(29-22(26)27)7-10-28-23(33)32-11-8-15(9-12-32)20-13-19(30-31(20)3)16-5-4-6-17(24)21(16)25/h4-6,13-15,18H,7-12H2,1-3H3,(H,28,33)(H4,26,27,29)/t18-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160743
(CHEMBL3785621)Show SMILES COc1ccc2C(N(Cc3ccccc3-c3ccccc3)C(=O)c2c1C)C(=O)NC(C)(C)C Show InChI InChI=1S/C28H30N2O3/c1-18-23(33-5)16-15-22-24(18)27(32)30(25(22)26(31)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25H,17H2,1-5H3,(H,29,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160707
(CHEMBL3785370)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccc(F)c(F)c3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C23H32Cl2N8O2/c1-31(2)21(34)17(29-22(26)27)7-10-28-23(35)33-11-8-14(9-12-33)19-13-18(30-32(19)3)15-5-4-6-16(24)20(15)25/h4-6,13-14,17H,7-12H2,1-3H3,(H,28,35)(H4,26,27,29)/t17-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160694
(CHEMBL3786683)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OCF Show InChI InChI=1S/C19H27Cl2N7O2S/c1-27-17(12-16(26-27)14-4-2-5-15(20)18(14)21)13-6-10-28(11-7-13)31(29,30)25-9-3-8-24-19(22)23/h2,4-5,12-13,25H,3,6-11H2,1H3,(H4,22,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 2.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160744
(CHEMBL3787356)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cccc(O)c12 Show InChI InChI=1S/C26H26N2O3/c1-26(2,3)27-24(30)23-22-20(14-9-15-21(22)29)25(31)28(23)16-18-12-7-8-13-19(18)17-10-5-4-6-11-17/h4-15,23,29H,16H2,1-3H3,(H,27,30) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160696
(CHEMBL3785555)Show SMILES COc1ccc2C(N(Cc3ccccc3-c3ccccc3)C(=O)c2c1)C(=O)NC(C)(C)C Show InChI InChI=1S/C27H38Cl2N8O2/c1-3-36(16-17-7-8-17)25(38)21(33-26(30)31)9-12-32-27(39)37-13-10-18(11-14-37)23-15-22(34-35(23)2)19-5-4-6-20(28)24(19)29/h4-6,15,17-18,21H,3,7-14,16H2,1-2H3,(H,32,39)(H4,30,31,33)/t21-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160699
(CHEMBL3786460)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)c(F)c2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160719
(CHEMBL3787412)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1NS(C)(=O)=O Show InChI InChI=1S/C28H31N3O4S/c1-18-23(30-36(5,34)35)16-15-22-24(18)27(33)31(25(22)26(32)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25,30H,17H2,1-5H3,(H,29,32) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 3.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160711
(CHEMBL3786440)Show SMILES COCCOCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccc(F)cc12 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-27(20(23)24)10-4-9-25-32(30,31)29-11-7-14(8-12-29)18-13-17(26-28(18)2)15-5-3-6-16(21)19(15)22/h3,5-6,13-14,25H,4,7-12H2,1-2H3,(H3,23,24) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160709
(CHEMBL3786093)Show SMILES CC(C)(C)NC(=O)C1N(C(c2cccnc2)c2cccnc2)C(=O)c2ccc(Cl)cc12 Show InChI InChI=1S/C23H35Cl2N7O2S/c1-15(2)13-17(29-23(26)27)7-10-28-35(33,34)32-11-8-16(9-12-32)21-14-20(30-31(21)3)18-5-4-6-19(24)22(18)25/h4-6,14-17,28H,7-13H2,1-3H3,(H4,26,27,29)/t17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160697
(CHEMBL3785335)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-13(27-20(24)25)6-9-26-21(31)30-10-7-14(8-11-30)18-12-17(28-29(18)2)15-4-3-5-16(22)19(15)23/h3-5,12-14H,6-11H2,1-2H3,(H,26,31)(H4,24,25,27)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160708
(CHEMBL3786775)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccc(F)cc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C20H29Cl2N7O2S/c1-28-18(13-17(27-28)15-5-4-6-16(21)19(15)22)14-7-11-29(12-8-14)32(30,31)26-10-3-2-9-25-20(23)24/h4-6,13-14,26H,2-3,7-12H2,1H3,(H4,23,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160693
(CHEMBL3786256)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1OS(C)(=O)=O Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160706
(CHEMBL3786473)Show SMILES CC(N1C(C(=O)NC(C)(C)CO)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C27H37Cl2N9O3/c1-17(39)36-12-14-37(15-13-36)25(40)21(33-26(30)31)6-9-32-27(41)38-10-7-18(8-11-38)23-16-22(34-35(23)2)19-4-3-5-20(28)24(19)29/h3-5,16,18,21H,6-15H2,1-2H3,(H,32,41)(H4,30,31,33)/t21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160704
(CHEMBL3785486)Show SMILES CCCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H27Cl2N7O3/c1-29-17(11-16(28-29)13-3-2-4-14(22)18(13)23)12-6-9-30(10-7-12)21(33)26-8-5-15(19(31)32)27-20(24)25/h2-4,11-12,15H,5-10H2,1H3,(H,26,33)(H,31,32)(H4,24,25,27)/t15-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160703
(CHEMBL3786013)Show SMILES O=C(NCc1ccncc1)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C20H27Cl2N7O/c1-28-17(12-16(27-28)14-4-2-5-15(21)18(14)22)13-6-10-29(11-7-13)20(30)26-9-3-8-25-19(23)24/h2,4-5,12-13H,3,6-11H2,1H3,(H,26,30)(H4,23,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160697
(CHEMBL3785335)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-13(27-20(24)25)6-9-26-21(31)30-10-7-14(8-11-30)18-12-17(28-29(18)2)15-4-3-5-16(22)19(15)23/h3-5,12-14H,6-11H2,1-2H3,(H,26,31)(H4,24,25,27)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160701
(CHEMBL3786519)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccc(F)cc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-3-11-30(22(25)26)12-5-10-27-34(32,33)31-13-8-16(9-14-31)20-15-19(28-29(20)2)17-6-4-7-18(23)21(17)24/h4,6-7,15-16,27H,3,5,8-14H2,1-2H3,(H3,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160702
(CHEMBL3787088)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C18H25Cl2N7O2S/c1-26-16(11-15(25-26)13-3-2-4-14(19)17(13)20)12-5-9-27(10-6-12)30(28,29)24-8-7-23-18(21)22/h2-4,11-12,24H,5-10H2,1H3,(H4,21,22,23) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160700
(CHEMBL3785765)Show SMILES CC(C)(C)NC(=O)C1N(Cc2cc(F)ccc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C23H33Cl2N7O/c1-14(2)18(29-22(26)27)7-10-28-23(33)32-11-8-15(9-12-32)20-13-19(30-31(20)3)16-5-4-6-17(24)21(16)25/h4-6,13-15,18H,7-12H2,1-3H3,(H,28,33)(H4,26,27,29)/t18-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160695
(CHEMBL3786868)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccc(cc12)C#N Show InChI InChI=1S/C23H33Cl2N7O/c1-3-11-31(22(26)27)12-5-10-28-23(33)32-13-8-16(9-14-32)20-15-19(29-30(20)2)17-6-4-7-18(24)21(17)25/h4,6-7,15-16H,3,5,8-14H2,1-2H3,(H3,26,27)(H,28,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160719
(CHEMBL3787412)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1NS(C)(=O)=O Show InChI InChI=1S/C28H31N3O4S/c1-18-23(30-36(5,34)35)16-15-22-24(18)27(33)31(25(22)26(32)29-28(2,3)4)17-20-13-9-10-14-21(20)19-11-7-6-8-12-19/h6-16,25,30H,17H2,1-5H3,(H,29,32) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
MMDB
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160718
(CHEMBL3786344)Show SMILES CCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C30H42Cl2N8O2/c1-38-26(17-25(37-38)22-7-4-8-23(31)27(22)32)20-11-14-39(15-12-20)30(42)35-13-9-24(36-29(33)34)28(41)40-16-10-19-5-2-3-6-21(19)18-40/h4,7-8,17,19-21,24H,2-3,5-6,9-16,18H2,1H3,(H,35,42)(H4,33,34,36)/t19?,21?,24-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160698
(CHEMBL3786562)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(ccc12)C#N Show InChI InChI=1S/C22H33Cl2N7O2S/c1-15(2)31(22(25)26)11-5-10-27-34(32,33)30-12-8-16(9-13-30)20-14-19(28-29(20)3)17-6-4-7-18(23)21(17)24/h4,6-7,14-16,27H,5,8-13H2,1-3H3,(H3,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160699
(CHEMBL3786460)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)c(F)c2)C(=O)c2ccccc12 Show InChI InChI=1S/C22H33Cl2N7O2S/c1-14(2)18(28-22(25)26)7-10-27-34(32,33)31-11-8-15(9-12-31)20-13-19(29-30(20)3)16-5-4-6-17(23)21(16)24/h4-6,13-15,18,27H,7-12H2,1-3H3,(H4,25,26,28)/t18-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160566
(CHEMBL3786255)Show SMILES CC(N1C(C(=O)NCc2ccccc2)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C24H22N2O2/c1-17(19-12-6-3-7-13-19)26-22(20-14-8-9-15-21(20)24(26)28)23(27)25-16-18-10-4-2-5-11-18/h2-15,17,22H,16H2,1H3,(H,25,27) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160706
(CHEMBL3786473)Show SMILES CC(N1C(C(=O)NC(C)(C)CO)c2ccccc2C1=O)c1ccccc1 Show InChI InChI=1S/C27H37Cl2N9O3/c1-17(39)36-12-14-37(15-13-36)25(40)21(33-26(30)31)6-9-32-27(41)38-10-7-18(8-11-38)23-16-22(34-35(23)2)19-4-3-5-20(28)24(19)29/h3-5,16,18,21H,6-15H2,1-2H3,(H,32,41)(H4,30,31,33)/t21-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160712
(CHEMBL3785768)Show SMILES CC(C)(CN1C(C(=O)NCCCF)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-13(26-20(23)24)6-9-25-32(30,31)29-10-7-14(8-11-29)18-12-17(27-28(18)2)15-4-3-5-16(21)19(15)22/h3-5,12-14,25H,6-11H2,1-2H3,(H4,23,24,26)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160711
(CHEMBL3786440)Show SMILES COCCOCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccc(F)cc12 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-27(20(23)24)10-4-9-25-32(30,31)29-11-7-14(8-12-29)18-13-17(26-28(18)2)15-5-3-6-16(21)19(15)22/h3,5-6,13-14,25H,4,7-12H2,1-2H3,(H3,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >3.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily A member 5
(Homo sapiens (Human)) | BDBM50160698
(CHEMBL3786562)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(ccc12)C#N Show InChI InChI=1S/C22H33Cl2N7O2S/c1-15(2)31(22(25)26)11-5-10-27-34(32,33)30-12-8-16(9-13-30)20-14-19(28-29(20)3)17-6-4-7-18(23)21(17)24/h4,6-7,14-16,27H,5,8-13H2,1-3H3,(H3,25,26) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 3.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human Kv1.5 channel by Rb-flux assay |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160713
(CHEMBL3787069)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2cc(O)ccc12 Show InChI InChI=1S/C21H29Cl2N7O/c1-29-18(13-17(28-29)15-5-4-6-16(22)19(15)23)14-7-11-30(12-8-14)21(31)27-10-3-2-9-26-20(24)25/h4-6,13-14H,2-3,7-12H2,1H3,(H,27,31)(H4,24,25,26) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160715
(CHEMBL3785865)Show SMILES Cc1c2C(=O)N(Cc3ccccc3-c3ccccc3)C(C(=O)NC(C)(C)C)c2ccc1O Show InChI InChI=1S/C21H29Cl2N7O/c1-28(20(24)25)10-4-9-26-21(31)30-11-7-14(8-12-30)18-13-17(27-29(18)2)15-5-3-6-16(22)19(15)23/h3,5-6,13-14H,4,7-12H2,1-2H3,(H3,24,25)(H,26,31) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50160712
(CHEMBL3785768)Show SMILES CC(C)(CN1C(C(=O)NCCCF)c2ccccc2C1=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C20H29Cl2N7O2S/c1-13(26-20(23)24)6-9-25-32(30,31)29-10-7-14(8-11-29)18-12-17(27-28(18)2)15-4-3-5-16(21)19(15)22/h3-5,12-14,25H,6-11H2,1-2H3,(H4,23,24,26)/t13-/m1/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 (unknown origin) |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50160718
(CHEMBL3786344)Show SMILES CCCNC(=O)C1N(CC(C)c2ccc(Cl)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C30H42Cl2N8O2/c1-38-26(17-25(37-38)22-7-4-8-23(31)27(22)32)20-11-14-39(15-12-20)30(42)35-13-9-24(36-29(33)34)28(41)40-16-10-19-5-2-3-6-21(19)18-40/h4,7-8,17,19-21,24H,2-3,5-6,9-16,18H2,1H3,(H,35,42)(H4,33,34,36)/t19?,21?,24-/m0/s1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 (unknown origin) |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160705
(CHEMBL3786303)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccc(F)cc2)C(=O)c2ccccc12 Show InChI InChI=1S/C23H33Cl2N7O/c1-15(2)32(22(26)27)11-5-10-28-23(33)31-12-8-16(9-13-31)20-14-19(29-30(20)3)17-6-4-7-18(24)21(17)25/h4,6-7,14-16H,5,8-13H2,1-3H3,(H3,26,27)(H,28,33) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 5.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50160565
(CHEMBL3786542)Show SMILES CC(C)(C)NC(=O)C1N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc12 Show InChI InChI=1S/C26H26N2O2/c1-26(2,3)27-24(29)23-21-15-9-10-16-22(21)25(30)28(23)17-19-13-7-8-14-20(19)18-11-5-4-6-12-18/h4-16,23H,17H2,1-3H3,(H,27,29) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
UniProtKB/TrEMBL
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 6.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of human ERG |
Bioorg Med Chem Lett 26: 2023-9 (2016)
Article DOI: 10.1016/j.bmcl.2016.02.081
BindingDB Entry DOI: 10.7270/Q2D220HH |
More data for this
Ligand-Target Pair | |
Search and Browse
